RecruitingNot ApplicableNCT06903676

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

Sponsor

Indiana University

Enrollment

50 participants

Start Date

Aug 5, 2025

Study Type

INTERVENTIONAL

Conditions

Pancreatitis Pancreatectomy

Summary

The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Older than 18 years of age
Undergoing elective pancreatectomy for any indication

Exclusion Criteria3

Younger than 18 years of age
Pregnant women
Prisoner

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETRP-2 Urine Dipstick

Urine dipstick testing for Trypsinogen-2

Locations(1)

Indiana University Health University Hospital

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06903676

Related Trials

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).

NCT075325902 locations

Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis

NCT073302841 location